» Articles » PMID: 35814697

Exposure to Nepalese Propolis Alters the Metabolic State of

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Jul 11
PMID 35814697
Authors
Affiliations
Soon will be listed here.
Abstract

Propolis is a natural product proved to be efficient against . Although it is produced by bees, its active alcoholic-aqueous fraction contains plant-derived molecules. To gain some insight into its mechanism of antimycobacterial activity, we studied the metabolic changes in bacterial cells treated with extract of sp. propolis from Nepal. The detailed metabolomic and transcriptomic analysis performed in this study indicated target points in bacterial cells under propolis extract influence. The profile of lipids forming the outer and middle layer of the mycobacterial cell envelope was not changed by propolis treatment, however, fluctuations in the profiles of amphipathic glycerophospholipids were observed. The enrichment analysis revealed bacterial metabolic pathways affected by sp. propolis treatment. The early metabolic response involved much more pathways than observed after 48 h of incubation, however, the highest enrichment ratio was observed after 48 h, indicating the long-lasting influence of propolis. The early bacterial response was related to the increased demand for energy and upregulation of molecules involved in the formation of the cell membrane. The transcriptomic analysis confirmed that bacteria also suffered from oxidative stress, which was more pronounced on the second day of exposure. This was the first attempt to explain the action of Nepalese propolis extract against mycobacteria.

Citing Articles

Molecular insight into thymoquinone mechanism of action against .

Jankowski G, Sawicki R, Truszkiewicz W, Wolan N, Ziomek M, Hryc B Front Microbiol. 2024; 15:1353875.

PMID: 38414774 PMC: 10896893. DOI: 10.3389/fmicb.2024.1353875.


Sulphides from garlic essential oil dose-dependently change the distribution of glycerophospholipids and induce N6-tuberculosinyladenosine formation in mycobacterial cells.

Sawicki R, Widelski J, Truszkiewicz W, Kawka S, Kai G, Sieniawska E Sci Rep. 2023; 13(1):20351.

PMID: 37990133 PMC: 10663513. DOI: 10.1038/s41598-023-47750-0.


Propolis and Their Active Constituents for Chronic Diseases.

Chavda V, Chaudhari A, Teli D, Balar P, Vora L Biomedicines. 2023; 11(2).

PMID: 36830794 PMC: 9953602. DOI: 10.3390/biomedicines11020259.


Nano-Delivery System of Ethanolic Extract of Propolis Targeting via Aptamer-Modified-Niosomes.

Sangboonruang S, Semakul N, Suriyaprom S, Kitidee K, Khantipongse J, Intorasoot S Nanomaterials (Basel). 2023; 13(2).

PMID: 36678022 PMC: 9861461. DOI: 10.3390/nano13020269.

References
1.
Newman D, Cragg G . Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803. DOI: 10.1021/acs.jnatprod.9b01285. View

2.
Chinsembu K . Tuberculosis and nature's pharmacy of putative anti-tuberculosis agents. Acta Trop. 2015; 153:46-56. DOI: 10.1016/j.actatropica.2015.10.004. View

3.
Manganelli R, Voskuil M, Schoolnik G, Dubnau E, Gomez M, Smith I . Role of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression. Mol Microbiol. 2002; 45(2):365-74. DOI: 10.1046/j.1365-2958.2002.03005.x. View

4.
Okinczyc P, Paluch E, Franiczek R, Widelski J, Wojtanowski K, Mroczek T . Antimicrobial activity of Apis mellifera L. and Trigona sp. propolis from Nepal and its phytochemical analysis. Biomed Pharmacother. 2020; 129:110435. DOI: 10.1016/j.biopha.2020.110435. View

5.
Salomon C, Schmidt L . Natural products as leads for tuberculosis drug development. Curr Top Med Chem. 2012; 12(7):735-65. DOI: 10.2174/156802612799984526. View